Avapritinib News
Avapritinib currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Avapritinib with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Unresectable or metastatic gastrointestinal stromal tumour (GIST) AYVAKYT is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal...
- Evidence level: L5
- Predicted indications (20):
- axial spondylometaphyseal dysplasia (99.9%)
- bilateral parasagittal parieto-occipital polymicrogyria (99.9%)
- amyotrophic lateral sclerosis (99.9%)
- trichomegaly-retina pigmentary degeneration-dwarfism syndrome (99.9%)
- amyotrophic lateral sclerosis, susceptibility to (99.9%)
- amyotrohpic lateral sclerosis type 22 (99.9%)
- lower motor neuron syndrome with late-adult onset (99.9%)
- lethal arthrogryposis-anterior horn cell disease syndrome (99.9%)
- monomelic amyotrophy (99.9%)
- Mills syndrome (99.9%)
- autosomal dominant mitochondrial myopathy with exercise intolerance (99.9%)
- familial generalized lentiginosis (99.9%)
- rhabdoid tumor (99.9%)
- gastrocutaneous syndrome (99.9%)
- acromelanosis (99.8%)
- congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome (99.8%)
- Moynahan syndrome (99.8%)
- osteopathia striata-pigmentary dermopathy-white forelock syndrome (99.8%)
- leukonychia totalis-acanthosis-nigricans-like lesions-abnormal hair syndrome (99.8%)
- peripheral nerve schwannoma (99.8%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.